Alberto Montero, MD, Oncology, Cleveland, OH

AlbertoJoseMonteroMDMBA, CPHQ

Oncology Cleveland, OH

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Clinical Director Breast Cancer Program UH/Seidman Cancer Center at University Hospitals

Dr. Montero is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Montero's full profile

Already have an account?

Education & Training

  • University of Miami School of BusinessMBA, 2011 - 2013
  • University of Texas MD Anderson Cancer CenterFellowship, Medical Oncology, 2002 - 2005
  • University of Texas Health Science Center - HoustonResidency, Internal Medicine, 1999 - 2002
  • University of Texas Medical BranchClass of 1999
  • University of Texas at AustinB.A., Summa Cum Laude, 1990 - 1994

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2022
  • FL State Medical License
    FL State Medical License 2008 - 2022
  • SC State Medical License
    SC State Medical License 2005 - 2009
  • TX State Medical License
    TX State Medical License 2002 - 2005
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Clinical Director, Breast Cancer Medical Oncology Program University Hospitals, 2020
  • Six Sigma Green Belt University of Miami School of Business, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Re: Xie, J, Diener M, De G et al Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative...  
    Diaby V, Adunlin G, Montero AJ, J Med Econ, 2/10/2014
  • Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L  
    Diaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ , Lichtenheld MG, Immunol Res, 11/12/2013
  • Breast Cancer Survival Poorer in Black Women: Commentary  
    Montero AJ, Healio/HemOnc Today, 8/1/2013
  • Join now to see all

Authored Content

  • We Don't Have All the Answers, and We Don't Have ToMay 2021

Press Mentions

  • Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual Meeting
    Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual MeetingMay 30th, 2019
  • Three Treatment Modalities Emerge for Patients with Triple-Negative Breast Cancer
    Three Treatment Modalities Emerge for Patients with Triple-Negative Breast CancerMarch 12th, 2019
  • The Top 10 Medical Disruptors of 2018
    The Top 10 Medical Disruptors of 2018October 26th, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish